Tags

Type your tag names separated by a space and hit enter

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
JAMA. 2021 06 01; 325(21):2201-2202.JAMA

Authors+Show Affiliations

CDC COVID-19 Response Team, Atlanta, Georgia.CDC COVID-19 Response Team, Atlanta, Georgia.CDC COVID-19 Response Team, Atlanta, Georgia.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33818592

Citation

Chapin-Bardales, Johanna, et al. "Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines." JAMA, vol. 325, no. 21, 2021, pp. 2201-2202.
Chapin-Bardales J, Gee J, Myers T. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. JAMA. 2021;325(21):2201-2202.
Chapin-Bardales, J., Gee, J., & Myers, T. (2021). Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. JAMA, 325(21), 2201-2202. https://doi.org/10.1001/jama.2021.5374
Chapin-Bardales J, Gee J, Myers T. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. JAMA. 2021 06 1;325(21):2201-2202. PubMed PMID: 33818592.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. AU - Chapin-Bardales,Johanna, AU - Gee,Julianne, AU - Myers,Tanya, PY - 2021/4/6/pubmed PY - 2021/6/8/medline PY - 2021/4/5/entrez SP - 2201 EP - 2202 JF - JAMA JO - JAMA VL - 325 IS - 21 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/33818592/Reactogenicity_Following_Receipt_of_mRNA_Based_COVID_19_Vaccines_ L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.5374 DB - PRIME DP - Unbound Medicine ER -